Rewey Asset Management, an investment management firm, released its “RAM Smid Composite” investor letter for the second quarter of 2026. A copy of the letter can be downloaded here. Rewey Asset Management, an investment management firm, released its “RAM Smid Composite” investor letter for the second quarter of 2026. RAM Smid Composite gained 20.06% in the second quarter of 2026, outperforming the Russell 2500 Value Total Return Index’s 18.50% return, while year to date performance reached 31.15% versus 24.16% for the benchmark. The firm views the Russell 2500 Value’s outperformance of the S&P 500’s 15.20% and the Magnificent 7’s 11.7% gains as evidence of a continued rotation toward undervalued small and smid cap stocks. Economic growth moderated after first quarter GDP was revised. Capital markets remained strong, with IPOs raising $104 billion across 48 deals. In addition, please check the Composite’s top five holdings to know its best picks in 2026.
In its second-quarter 2026 investor letter, Rewey Asset Management highlighted Orthofix Medical Inc. (NASDAQ:OFIX). Orthofix Medical Inc. (NASDAQ:OFIX) operates as a medical technology company. On July 22, 2026, Orthofix Medical Inc. (NASDAQ:OFIX) closed at $11.02 per share. One-month return of Orthofix Medical Inc. (NASDAQ:OFIX) was 27.03% and its shares gained 4.14% over the past 52 weeks. Orthofix Medical Inc. (NASDAQ:OFIX) has a market capitalization of $441.80 million with a 52-week trading range between $8.85 – $16.99.
Rewey Asset Management stated the following regarding Orthofix Medical Inc. (NASDAQ:OFIX) in its Q2 2026 investor letter:
“Orthofix Medical Inc. (NASDAQ:OFIX) was our weakest performer in 1Q26, as the stock declined following its May 21st announcement that CMS had lowered its reimbursement for non-invasive bone growth stimulator devices. Due to the change OFIX reduced its revenue guidance by $5 million for 2026 and withdrew its prior 3-year targets. While clearly a disappointment, this news was not a company driven negative. We still forecast revenue and earnings growth for OFIX over the next few years and believe the share decline is overdone. Incredibly, on July 1st, CMS completely reversed this code change, a net positive for OFIX.”
Orthofix Medical Inc. (NASDAQ:OFIX) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held Orthofix Medical Inc. (NASDAQ:OFIX) at the end of the first quarter which was 24 in the previous quarter. While we acknowledge the risk and potential of Orthofix Medical Inc. (NASDAQ:OFIX) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Orthofix Medical Inc. (NASDAQ:OFIX) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Orthofix Medical Inc. (NASDAQ:OFIX) and shared best small-cap growth stocks to invest in. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
